MiniMed has added a dual glucose-ketone sensor from Abbott to its portfolio. The sensor is intended to track ketones, which can help identify the risk of diabetic ketoacidosis earlier. The development is part of a partnership between MiniMed and Abbott, although the scope and details of this partnership, as well as its impact on their respective businesses, are not entirely clear.